Budesonide Inhalation Suspension
Product Images NDC 50090-7126

11 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 50090-7126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 01)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 01)
Chemical structure diagram of the active ingredient budesonide in the inhalation suspension product. The image shows detailed molecular bonding and groups characteristic of budesonide.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 02)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 02)
A line graph titled 'Nighttime Asthma Change from Baseline' showing mean change in nighttime asthma symptoms over 12 weeks. The x-axis denotes time intervals from baseline through weeks 0-12, and the y-axis shows mean change from baseline. Four lines represent placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily dosages, with all treatment groups showing greater symptom reduction compared to placebo. P-values for each dosage group compared to placebo are listed below the graph.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 03)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 03)
A line graph titled 'Nighttime Asthma Change from Baseline' showing mean change from baseline nighttime asthma symptoms over 12 weeks. The x-axis is labeled with baseline and weekly intervals, and the y-axis shows mean change values from -0.6 to 0.1. Three data series are shown: placebo, 0.25 mg twice daily, and 0.5 mg twice daily. The graph tracks symptom changes, with placebo maintaining near baseline levels and both dosages showing decreases in symptoms over time. P-values for 0.25 mg and 0.5 mg doses are 0.022 and 0.021 respectively.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 04)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 04)
A line graph depicting nighttime asthma symptom changes from baseline over 12 weeks for various budesonide inhalation dosages and placebo. The y-axis shows mean change from baseline, and the x-axis shows time intervals from baseline to week 12. Five lines represent placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily dosages with corresponding p-values listed below the graph.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 05)

FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 06)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 06)
An instructional illustration showing a hand holding a blister pack of medication and another hand peeling back the foil backing to access a dose. This likely demonstrates how to remove a dose from the package for budesonide inhalation suspension use.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 07)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 07)
An instructional illustration showing a hand holding a small vial or ampule by the top. An arrow curves around the bottom, indicating a twisting or turning motion to open the vial, typically used for a respiratory inhalation suspension like budesonide inhalation.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 08)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 08)
An instructional illustration showing a person holding an ampule with both hands. The right hand is positioned to twist or snap off the top of the ampule, indicated by a curved arrow pointing in a clockwise direction around the top portion.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 09)

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 09)
An instructional line drawing showing one hand holding a medication cup while the other hand squeezes a liquid suspension from a vial or ampule into the cup, illustrating the preparation of budesonide inhalation suspension for respiratory inhalation use.*
FDA Label Image

Image (3315e8ee F729 4dab 86e4 349ab1c9c9ca 10)

FDA Label Image

Label Image (Lbl500907126)

Label Image (Lbl500907126)
Label for budesonide inhalation suspension 0.5 mg/2 mL by A-S Medication Solutions. The label indicates each single-dose ampule delivers 2 mL of a sterile suspension. It includes storage instructions to keep between 36 to 77 degrees Fahrenheit and protect from light. The package contains 30 single-dose ampules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.